3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
25
Carcinoma, Hepatocellular
22
Small Cell Lung Carcinoma
17
Lung Neoplasms
14
Neoplasms
13
Breast Neoplasms
9
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Squamous Cell Carcinoma of Head and Neck
6
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Prostatic Neoplasms
5
Melanoma
5
Carcinoma, Transitional Cell
5
Uterine Cervical Neoplasms
4
Sarcoma
4
Neoplasm Metastasis
4
Glioblastoma
4
Stomach Neoplasms
3
Solid Tumors
3
Sarcoma, Alveolar Soft Part
3
Liver Neoplasms
3
Extensive Stage Lung Small Cell Carcinoma
3
Endometrial Neoplasms
3
Carcinoma
3
Treatment-Refractory Solid Tumors
2
Small Cell Lung Cancer Extensive Stage
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Osteosarcoma
2
Interventions
Cyclophosphamide
30
Rituximab
26
Biopsy
23
Specimen Handling
20
Magnetic Resonance Spectroscopy
18
fludarabine
14
Prednisone
13
Vincristine
11
obinutuzumab
10
Lenalidomide
10
Etoposide
10
Doxorubicin
10
Bendamustine Hydrochloride
9
pembrolizumab
7
venetoclax
6
fludarabine phosphate
6
X-Rays
6
Tacrolimus
6
Nuclear Medicine Department, Hospital
6
Dexamethasone
6
Bortezomib
6
trametinib
5
ibrutinib
5
glofitamab
5
acalabrutinib
5
Mycophenolic Acid
5
Gemcitabine
5
Crizotinib
5
Busulfan
5
copanlisib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
atezolizumab
×
90 days
×
Clear all
No trials found.